Substance AbuseCASPARNCT01813864
Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR)
A study testing CASPAR/Treatment Planning in people with Substance Abuse, run by Treatment Research Institute at 7 sites in United States.
Trial summary
The proposed Quality Improvement Initiative study is a health services research project in community-based substance abuse treatment programs. The primary goals are to use training and technology transfer to match services to client needs, increase the number of services received by clients, and improve client… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Substance Abuse
- What is being tested?
- CASPAR/Treatment Planning
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 352 participants
- Where
- 7 sitesUnited States
- Study dates
- Aug 2004to Jul 2010
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- currently attending substance abuse treatment
Who cannot join
- incarceration
- under 18
Trial locations and contacts
7 sites in 1 country.
7 sites in 1 country
United States7 sites
Aldie Counseling
Bensalem, Pennsylvania, 19020
SODAT
Camden, New Jersey, 08103
Cape Counseling
Cape May Court House, New Jersey, 08210
Genesis Counseling
Collingswood, New Jersey, 08108
Aldie Counseling
Doylestown, Pennsylvania, 19118
Malvern Institute
King of Prussia, Pennsylvania, 19406
SODAT
Woodbury, New Jersey, 08096
About this study
The proposed Quality Improvement Initiative study is a health services research project in community-based substance abuse treatment programs. The primary goals are to use training and technology transfer to match services to client needs, increase the number of services received by clients, and improve client outcomes. This is a two phase study in which we compare clients pre-intervention to clients post-intervention.
Clients from Phase II (Post-Intervention) compared to Phase I (Pre-Intervention) will:have treatment plans that better match the problems reported at assessment; receive services that better match their needs, as reported during the assessment/intake; show better results during treatment performance on the Treatment Services Review (TSR), including attending a greater percentage of their scheduled treatment sessions and increased satisfaction with the Treatment Planning process; show better client outcomes at 3 month follow-up on primary drug and alcohol measures, including Breathalyzer and urine drug screen, and secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.
Read the detailed description
This protocol will specifically target identified organizational barriers by implementing the CASPAR system as a site-wide Quality Improvement Initiative (QI Initiative) study and enrolling seven sites in Bucks and Montgomery Counties in Pennsylvania and in the Southern New Jersey region who (1) were the most active sites in participating in the focus groups and provided feedback that led to the development of the new Quality Improvement protocol, (2) want to focus organizational effort and attention on improving treatment planning and problem-services matching, (3) met additional inclusion criteria (detailed below). They are all located within Bucks and Montgomery Counties in Pennsylvania and within a 70 mile radius of Atlantic City, New Jersey.
Executive directors at all invited programs will sign a Letter of Agreement (LoA) with Treatment Research Institute (TRI) that as an organization they will support their counselors in attending training, providing individualized treatment plans as well as monthly individualized sessions dedicated to problem-service matching; will add items necessary to their assessment to make sure it is equally comprehensive as the Addiction Severity Index (ASI), and will allow TRI to recruit clients for follow-up to evaluate the effectiveness of the QI Initiative implementation. The LoA will detail all site-specific expectations, along with benefits to the program, including free counselor and supervisor training (along with Certified Addictions Counselor (CAC) and Certified Alcohol Drug Counselor (CADC) credits), free software, and monetary compensation, $2,000 for site participation in Phase I of the study and $3,000 for site participation in Phase II of the study. Directors will also be provided with a detailed Director Information Sheet outlining aspects of the Quality Improvement Initiative outlined in the LoA.
TRI staff will provide counselors and supervisors with the treatment planning training as well as the CASPAR Resource Guide software and training on its use. These activities will be initiated as an organization-wide Quality Improvement Initiative, and as such, will be implemented with all counselors at each program. No data will be collected from the counselors, nor will we discuss or report on client outcomes grouped by counselor.
This will be a 2-Phase project. TRI staff will recruit up to 6 eligible clients per counselor prior to providing the CASPAR training and up to 6 additional clients after providing training. Based on current data from the sites, we expect a minimum of 36 counselors to be involved in the Quality Improvement Initiative.
Update June 1st 2009 - Based on current recruitment levels achieved and analysis needs, we are projecting recruitment of approximately 320 subjects.
We will continue to evaluate the effectiveness of this enhanced protocol by addressing the same aims and using primarily the same client instruments previously approved by this Institutional Review Board (IRB, some have been modified, see full discussion below). We will compare client outcomes before (Phase I) and after the individualized treatment planning and problem-service matching components are introduced (Phase II). As before, we expect to see pre-post differences in problem-treatment plan matching, treatment plan-service matching, and in the number and appropriateness of services clients receive; we also expect to see pre-post differences in client outcome such as treatment attendance, treatment retention, breathalyzer, and urinalysis results, the same measures and outcomes in the original design.
- Conditions
- Substance Abuse
- Being tested
- CASPAR/Treatment Planning
- Keywords
- treatment planning, resource guide, service matching, Service matching for substance abuse clients, CASPAR resource guide, Improved treatment planning
- Medical subject headings
- Substance-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CASPAR/Treatment PlanningBehavioural
Also called CASPAR, Technology Tranfer, Assessment
All counselors in the study will receive additional training in treatment planning and the CASPAR Resource Guide software to easily identify and link patients to services not available at substance abuse treatment centers such as General Educational Development (GED) training, dental clinics, job training, etc.
| Study group | Role | What they receive |
|---|---|---|
| CASPAR Resource Guide | Experimental | Treatment Enhanced/CASPAR-- All counselors in this study will receive a training and take part in the experimental arm of the study in Phase 2. Receives: Behavioral: CASPAR/Treatment Planning |
What is being measured
The primary outcome is the main question the study is designed to answer.
Better client outcomes at 3 month follow-up on primary drug and alcohol measures
Measured: 3 months post treatment start.
Secondary outcomes (3)
Better client outcomes at 3 month follow-up on secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.
Measured: 3-months post treatment start.
Increased satisfaction with the Treatment Planning process.
Measured: Assessed at 2, 4, 8 and 12 weeks.
Improved match between patient problems and treatment plan & services received.
Improved match between:
- Patient problems identified at admission and treatment plan.
- Patient problems identified at admission and services received.
Measured: Up to 3-months post treatment start.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2013 (estimated)
- Study startAug 2004
- Primary completionMar 2010
- Study completionJul 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Substance AbuseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 352 participants (actual)
Sponsor and investigators
- Lead sponsor
- Treatment Research Institute
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Responsible party
- Sponsor
- Investigators
- Deni Carise, PhD., Principal investigator, Treatment Research Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01813864
- Sponsor's protocol ID
- R01DA015125
- Other IDs
- 5R01DA015125-05
- Acronym
- CASPAR
- Status last verified
- Mar 2023
- First submitted
- 24 Jun 2010
- Last updated
- 28 Mar 2023
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR)
- ClinicalTrials.gov ID
- NCT01813864
- Acronym / sponsor ID
- CASPAR / R01DA015125
- Conditions
- Substance Abuse
- Keywords
- treatment planning, resource guide, service matching, Service matching for substance abuse clients, CASPAR resource guide, Improved treatment planning
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 352 participants (actual)
- Lead sponsor
- Treatment Research InstituteUniversity, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Study start
- Aug 2004
- Primary completion
- Mar 2010 (actual)
- Study completion
- Jul 2010 (actual)
- First posted
- 19 Mar 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The proposed Quality Improvement Initiative study is a health services research project in community-based substance abuse treatment programs. The primary goals are to use training and technology transfer to match services to client needs, increase the number of services received by clients, and improve client outcomes. This is a two phase study in which we compare clients pre-intervention to clients post-intervention.
Clients from Phase II (Post-Intervention) compared to Phase I (Pre-Intervention) will:have treatment plans that better match the problems reported at assessment; receive services that better match their needs, as reported during the assessment/intake; show better results during treatment performance on the Treatment Services Review (TSR), including attending a greater percentage of their scheduled treatment sessions and increased satisfaction with the Treatment Planning process; show better client outcomes at 3 month follow-up on primary drug and alcohol measures, including Breathalyzer and urine drug screen, and secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.
Detailed description
This protocol will specifically target identified organizational barriers by implementing the CASPAR system as a site-wide Quality Improvement Initiative (QI Initiative) study and enrolling seven sites in Bucks and Montgomery Counties in Pennsylvania and in the Southern New Jersey region who (1) were the most active sites in participating in the focus groups and provided feedback that led to the development of the new Quality Improvement protocol, (2) want to focus organizational effort and attention on improving treatment planning and problem-services matching, (3) met additional inclusion criteria (detailed below). They are all located within Bucks and Montgomery Counties in Pennsylvania and within a 70 mile radius of Atlantic City, New Jersey.
Executive directors at all invited programs will sign a Letter of Agreement (LoA) with Treatment Research Institute (TRI) that as an organization they will support their counselors in attending training, providing individualized treatment plans as well as monthly individualized sessions dedicated to problem-service matching; will add items necessary to their assessment to make sure it is equally comprehensive as the Addiction Severity Index (ASI), and will allow TRI to recruit clients for follow-up to evaluate the effectiveness of the QI Initiative implementation. The LoA will detail all site-specific expectations, along with benefits to the program, including free counselor and supervisor training (along with Certified Addictions Counselor (CAC) and Certified Alcohol Drug Counselor (CADC) credits), free software, and monetary compensation, $2,000 for site participation in Phase I of the study and $3,000 for site participation in Phase II of the study. Directors will also be provided with a detailed Director Information Sheet outlining aspects of the Quality Improvement Initiative outlined in the LoA.
TRI staff will provide counselors and supervisors with the treatment planning training as well as the CASPAR Resource Guide software and training on its use. These activities will be initiated as an organization-wide Quality Improvement Initiative, and as such, will be implemented with all counselors at each program. No data will be collected from the counselors, nor will we discuss or report on client outcomes grouped by counselor.
This will be a 2-Phase project. TRI staff will recruit up to 6 eligible clients per counselor prior to providing the CASPAR training and up to 6 additional clients after providing training. Based on current data from the sites, we expect a minimum of 36 counselors to be involved in the Quality Improvement Initiative.
Update June 1st 2009 - Based on current recruitment levels achieved and analysis needs, we are projecting recruitment of approximately 320 subjects.
We will continue to evaluate the effectiveness of this enhanced protocol by addressing the same aims and using primarily the same client instruments previously approved by this Institutional Review Board (IRB, some have been modified, see full discussion below). We will compare client outcomes before (Phase I) and after the individualized treatment planning and problem-service matching components are introduced (Phase II). As before, we expect to see pre-post differences in problem-treatment plan matching, treatment plan-service matching, and in the number and appropriateness of services clients receive; we also expect to see pre-post differences in client outcome such as treatment attendance, treatment retention, breathalyzer, and urinalysis results, the same measures and outcomes in the original design.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| CASPAR Resource Guide | Experimental | Behavioral: CASPAR/Treatment PlanningTreatment Enhanced/CASPAR-- All counselors in this study will receive a training and take part in the experimental arm of the study in Phase 2. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- currently attending substance abuse treatment
Key exclusion criteria (2 listed)
- incarceration
- under 18
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CASPAR/Treatment PlanningAlso: CASPAR, Technology Tranfer, AssessmentAll counselors in the study will receive additional training in treatment planning and the CASPAR Resource Guide software to easily identify and link patients to services not available at substance abuse treatment centers such as General Educational Development (GED) training, dental clinics, job training, etc. | Behavioural | CASPAR Resource Guide |
Primary outcome
Better client outcomes at 3 month follow-up on primary drug and alcohol measures
Time frame: 3 months post treatment start.
3 secondary outcomes
Better client outcomes at 3 month follow-up on secondary personal health and social functioning measures such as days medical problems, days psychiatric problems, days employed, days of conflict with family members, etc.
Time frame: 3-months post treatment start.
Increased satisfaction with the Treatment Planning process.
Time frame: Assessed at 2, 4, 8 and 12 weeks.
Improved match between patient problems and treatment plan & services received.
Time frame: Up to 3-months post treatment start.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Mar 2023.
Related trials for Substance Abuse
RecruitingPhase 3
Nabilone for Agitation Blinded Intervention Trial
Alzheimer Disease, Agitation
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
Active, not recruitingPhase 1
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Tobacco Use Disorder, Nicotine Dependence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Deni Carise, PhD. principal investigator
Treatment Research Institute
7 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing CASPAR/Treatment Planning in people with Substance Abuse, run by Treatment Research Institute at 7 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 7 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Better client outcomes at 3 month follow-up on primary drug and alcohol measures (time frame: 3 months post treatment start.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2023.